Home
Market Capitalization of Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
Market Cap
Key Highlights
- The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 169.5 crore as of 07 May 25 .
- The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 71.65 as of 07 May 15:30 .

Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
Share Price
Market Price of Bafna Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
07 May 2025 | 71.65 |
06 May 2025 | 75 |
05 May 2025 | 76.57 |
02 May 2025 | 80.6 |
30 Apr 2025 | 77.23 |
29 Apr 2025 | 79 |
28 Apr 2025 | 82.41 |
25 Apr 2025 | 79.74 |
24 Apr 2025 | 75.95 |
23 Apr 2025 | 74 |
SWOT Analysis Of Bafna Pharmaceuticals Ltd
BlinkX Score for Bafna Pharmaceuticals Ltd
Asset Value vs Market Value of Bafna Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Bafna Pharmaceuticals Ltd
Historical P/E Ratio of Bafna Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Bafna Pharmaceuticals Ltd
Historical Revenue of Bafna Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Bafna Pharmaceuticals Ltd
Historical EBITDA of Bafna Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Bafna Pharmaceuticals Ltd
Historical Net Profit of Bafna Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Bafna Pharmaceuticals Ltd
Dividend Payout Over Time
About Bafna Pharmaceuticals Ltd
- Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
- The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
- Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
- During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.
Bafna Pharmaceuticals Ltd News Hub
Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter
Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains
Read more
13 Aug 24
Bafna Pharmaceuticals to declare Quarterly Result
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
10 Aug 24
Bafna Pharmaceuticals to convene AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
04 Sept 24
Bafna Pharmaceuticals schedules AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
05 Sept 24